Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy.
Resting-state functional connectivity in multiple sclerosis: An examination of group differences and individual differences.
Oral laquinimod for multiple sclerosis: beyond the anti-inflammatory effect.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Employment and multiple sclerosis: Policy, programming, and research recommendations.
Job placement interventions for people with multiple sclerosis.
Clinical and demographic factors affecting disease severity in patients with multiple sclerosis.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Correlation of multiple sclerosis (MS) incidence trends with solar and geomagnetic indices: Time to revise the method of reporting MS epidemiological data.
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
Multiple sclerosis: Quadrivalent HPV vaccination does not increase risk of MS.
Anthocyanins suppress the secretion of proinflammatory mediators and oxidative stress, and restore ion pump activities in demyelination.
Secondary Health Conditions in Individuals With Multiple Sclerosis: A Cross-Sectional Web-Based Survey Analysis.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Effective communication at the point of multiple sclerosis diagnosis.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
Redefining Self: Patients' Decision Making About Treatment for Multiple Sclerosis.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »